Anti-IL-39 (IL-23p19/Ebi3) polyclonal antibodies ameliorate autoimmune symptoms in lupus-like mice

The interleukin (IL)-12 family cytokines have been examined as therapeutic targets in the treatment of several autoimmune diseases. Our previous study showed that a novel IL-12 family cytokine, IL-39 (IL-23p19/Ebi3) mediates inflammation in lupus-like mice. In the present study, the effect of anti-m...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Xiaoqian, Zhang, Yu, Wang, Zhiding, Liu, Xiaoling, Zhu, Gaizhi, Han, Gencheng, Chen, Guojiang, Hou, Chunmei, Wang, Tianxiao, Shen, Beifen, Li, Yan, Xiao, He, Ma, Ning, Wang, Renxi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2018
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5780108/
https://www.ncbi.nlm.nih.gov/pubmed/29138852
http://dx.doi.org/10.3892/mmr.2017.8048

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5780108/
https://www.ncbi.nlm.nih.gov/pubmed/29138852
http://dx.doi.org/10.3892/mmr.2017.8048

Ejemplares similares